Remodeling of heart in patients with stable ischemic heart disease combined with chronic obstructive pulmonary disease as a basis for development of heart failure
DOI:
https://doi.org/10.26641/2307-0404.2022.1.254319Анотація
The aim of this study was to determine phenotypes of remodeling of heart and the status of systolic and diastolic function in patients with ischemic heart disease (IHD) combined with chronic obstructive pulmonary disease (COPD) with early symptoms and signs of heart failure (HF). We enrolled 108 males with stable IHD and spirometrically confirmed COPD which preceded the manifestations of IHD – the main group (group 1). As comparison groups 30 males with stable IHD (group 2) and 30 males with COPD (group 3) were examined. Control group included 30 males without IHD and respiratory diseases. All groups were comparable in age, groups 1 and 2 – in the duration of IHD, groups 1 and 3 – in the duration of COPD. The patients of the group 1 were divided into 3 subgroups: subgroup 1 – 45 patients with stable angina, subgroup 2 – 27 patients with postinfarction cardiosclerosis, subgroup 3 –36 patients with combination of stable IHD and arterial hypertension (AH) without history of myocardial infarction. The patients of group 1 had different phenotypes of heart remodeling, which depended on the clinical forms of IHD, the presence of concomitant AH, the severity of bronchial obstruction. The patients of subgroup 1 in 60.0% cases had concentric remodeling and concentric left ventricular hypertrophy (LVH), in 26.7% – normal LV geometry, in all these cases ejection fraction (EF) was preserved. Only in 13.3% of cases eccentric LVH with mildly reduced EF was found. 59.3% of patients in subgroup 2 had eccentric LVH, left atrium dilatation and 55.6% had reduced EF. All patients of subgroup 3 had concentric direction of LV remodeling. The phenotypes of HF with reduced and mildly reduced EF were accompanied by impaired LV diastolic function. In assessing the likelihood of HF with preserved EF the HFA-PEFF score showed better accuracy. Pulmonary hypertension had a mixed cause with predominance of postcapillar component.
Посилання
[Adapted evidence-based clinical guideline “Chronic obstructive pulmonary disease”]. Kyiv: National Academy of Medical Sciences. 2020. p. 70. Ukrainian. Available from: http://www.ifp.kiev.ua/ftp1/metoddoc/nastanova_hozl_2020.pdf
Antomonov MYu. [Mathematical processing and analysis of biomedical data]. 2nd ed. MITC "Medinform"; 2018. p. 579. Russian.
Potabashnii VA. [The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease]. Medicni perspektivi. 2018;23(3):161-71. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2018.3(part1).142364
[Order of the Ministry of Health of Ukraine dated March 2, 2016 No. 152 “On Approval and Implementation of Medical-Technological Documents for the Standardization of Medical Assistance in Stable Ischemic Heart Disease”]. Kyiv; 2016. Ukrainian. Available from: https://www.dec.gov.ua/wp-content/uploads/2019/11/2016_152_ykpmd_ihs.pdf
[Recommendations of the Ukrainian Association of Cardiology. Comorbidity in chronic heart failure. Chronic obstructive pulmonary disease in chronic heart failure]. Sertseva nedostatnist. Klinichna praktyka. 2020;2:45-53. Ukrainian. Available from: https://www.researchgate.net/publication/346463261
Reddy Y, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138:861-70. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.034646
Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2019;40:3297-317. doi: https://doi.org/10.1093/eurheartj/ehz641
Recommendations for cardiac chamber quantification by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39. doi: https://doi.org/10.1016/j.echo.2014.10.003
Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocadiogr. 2016;29:277-314. doi: https://doi.org/10.1016/j.echo.2016.01.011
Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(1):16-37. doi: https://doi.org/10.1002/ejhf.1029
Sanders-van Wijk S, Aizpurua AB, Brunner-La Rocca HP, Henkens M, Weerts J, Knackstedt C, et al. The HFA-PEFF and H2FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(5):838-40. doi: https://doi.org/10.1002/ejhf.2019
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et.al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23:352-80. doi: https://doi.org/10.1002/ejhf.2115
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-77. doi: https://doi.org/10.1093/eurheartj/ehz425
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;00:1-111. doi: https://doi.org/10.1093/eurheartj/ehab484
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;00:1-128. doi: https://doi.org/10.1093/eurheartj/ehab368
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2022 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.